BridgeMD
New treatment option for Dermatitis, Atopic
Official title A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov ID: NCT07230860
What this study is testing
What is JNJ-95597528?
JNJ-95597528 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for dermatitis, atopic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to assess how well JNJ-95597528 works compared to placebo in participants with moderate to severe atopic dermatitis (AD).
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Be otherwise healthy on the basis of physical examination, medical history, vital signs, and 12-lead electrocardiogram (ECG) performed at screening
- Meets all the following disease activity criteria: a. Chronic atopic dermatitis (AD), according to American Academy of Dermatology Consensus Criteria...
- Must sign an informed consent form (ICF) indicating that the participant understands the purpose of, and procedures required for, the study and is...
- If willing to participate in the substudy, must sign a separate ICF for the corresponding substudy (or substudies)
- Willing and able to comply with scheduled visits, treatment plan, laboratory tests, lifestyle restrictions, and other study procedures
You likely can't join if
- History of substance abuse or alcohol abuse within 1 year before screening
- In the investigator's opinion, any clinically significant results from the 12-lead ECG, chemistry, hematology, or urinalysis laboratory tests...
- Known or suspected immunodeficiency, including history of invasive opportunistic infections
- Previously received JNJ-95597528
- Has known hypersensitivity or intolerance to JNJ-95597528 or its excipients or to any biologic medication or known allergies, or clinically...
The study team makes the final eligibility decision.
Where it's taking place
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Santa Ana, California, United States
- Miami, Florida, United States
- Rolling Meadows, Illinois, United States
- Indianapolis, Indiana, United States
- Detroit, Michigan, United States
- Fargo, North Dakota, United States
- Portland, Oregon, United States
- Philadelphia, Pennsylvania, United States
- Houston, Texas, United States
- San Antonio, Texas, United States
- Buenos Aires, Argentina
- CABA, Argentina
- Córdoba, Argentina
- Rosario, Argentina
- San Miguel de Tucumán, Argentina
- Curitiba, Brazil
- Porto Alegre, Brazil
- Rio de Janeiro, Brazil
+ 34 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fountain Valley, California, United States; Los Angeles, California, United States; Santa Ana, California, United States; Miami, Florida, United States; Rolling Meadows, Illinois, United States; Indianapolis, Indiana, United States and 48 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.